title: The effect of magnesium sulfate on bleeding time and nitric oxide production in preeclamsia.
abstract: Preeclampsia is a disease regarding with altered vascular reactivity leading to hypertension of the mother and metabolic alterations in the fetus. This study aimed to assess nitric oxide and bleeding time following administration of magnesium sulfate to preeclamtic patients compared to normotensive pregnant women. A total of 112 subjects (56 preeclamtic patients and 56 normotensive pregnant controls) were enrolled in this case-control study. Cases and controls were matched for age, BMI, gestational age, parity and gravidity. Total concentration of nitrite and nitrate (NOx) was measured before and during magnesium sulfate (MgSO4) treatment using a modified Griess-based method.
  
  
  RESULTS
  Systolic and diastolic blood pressures were significantly decreased during MgSO4 treatment in preeclamtic patients (p < 0.0001). NOx levels were significantly increased in preeclamtic women after MgSO4 administration (33.7 +/- 18.5 vs. 50.2 +/- 21.6, p < 0.0001) but it was not seen in normotensive parturients (52.4 +/- 28.9 vs. 57.3 +/- 21.7, p = 0.362). The bleeding time was scarcely increased following magnesium sulfate treatment in preeclamptic patients compared to normotensive pregnant women but it was not significant (p = 0.18). In addition, there was only a significantly reverse correlation between NOx levels and systolic or diastolic blood pressure in preeclamtic parturients after MgSO4 treatment (r = -0384; p = 0.003 and r = -0.29; p = 0.03, respectively). This study demonstrates that administrating MgSO4 to preeclamtic patients induced significant changes in NOx production which had a major role in modulating vasculature changes in preeclamsia.
authors.affiliation: Department of Gynecology and Obstetrics, Imam Khomeini Teaching Hospital, Mazandaran University of Medical Sciences, Sari, Iran.
authors.forename: Narges
authors.initials: N
authors.lastname: Moslemizade
authors.forename: Alireza
authors.initials: A
authors.lastname: Rafiei
authors.forename: Fereshteh
authors.initials: F
authors.lastname: Yazdani
authors.forename: Zahra
authors.initials: Z
authors.lastname: Hosseini-khah
authors.forename: Keyvan
authors.initials: K
authors.lastname: Yusefnezhad
mesh_terms: D000328:Adult; D001760:Bleeding Time; D001794:Blood Pressure; D015992:Body Mass Index; D005260:Female; D005865:Gestational Age; D020073:Gravidity; D006801:Humans; D008278:Magnesium Sulfate / Q000378:metabolism / Q000494:pharmacology*; D009566:Nitrates / Q000378:metabolism; D009569:Nitric Oxide / Q000737:chemistry*; D009573:Nitrites / Q000737:chemistry / Q000378:metabolism; D010298:Parity; D011225:Pre-Eclampsia / Q000188:drug therapy* / Q000517:prevention & control; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular
chemical_list: D009566:Nitrates; D009573:Nitrites; D009569:Nitric Oxide; D008278:Magnesium Sulfate